WECHSLER AMY B 4
4 · Bausch Health Companies Inc. · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Bausch Health (BHC) Director Amy Wechsler Receives 1,394 RSUs
What Happened
Amy B. Wechsler, a director of Bausch Health Companies Inc. (BHC), was granted 1,394 restricted share units (RSUs) on 2026-06-30. The filing reports an acquisition value of $4.93 per unit, for a total reported value of $6,872. This was an award/compensation grant (not an open-market purchase or sale).
Key Details
- Transaction date and price: 2026-06-30 at $4.93 per RSU (reported acquisition value).
- Shares/units received: 1,394 RSUs; total reported value $6,872.
- Shares owned after transaction: Not specified in the provided filing.
- Footnote: F1 — RSUs were issued in lieu of cash board compensation for the quarter ending 6/30/2026; each RSU is a contingent right to receive one common share.
- Filing date: 2026-07-02; no late-filing flag was indicated in the supplied data.
Context
RSUs are typically compensation awards that convert to actual shares only upon vesting or settlement; they represent a contingent right to receive stock rather than an immediate market purchase. Grants to directors as board compensation are common and do not by themselves indicate a personal buy/sell decision about the company’s near-term prospects.
Insider Transaction Report
- Award
Common Shares, No Par Value
[F1]2026-06-30$4.93/sh+1,394$6,872→ 314,979 total
Footnotes (1)
- [F1]Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.